Optimized Medium For CAR-T Cell Therapy Development: NB-ROC™ T Cell SF Medium

NB-ROC is a media specifically designed for the development of CAR-T cell therapy. It aims to enhance transduction while preserving essential characteristics, which results in a higher yield of CAR+ cells and improved patient outcomes. NB-ROC also decreases the quantity of viral vector required, reducing production costs and increasing the safety of the final therapeutic dose. The media aids cell proliferation and maintains quality indicators such as cell health and viability, leading to more effective and safer cancer treatments through T cell immunotherapy. Produced in a GMP environment, NB-ROC holds ISO 13485:2016 certification and comes with a Certificate of Compliance or Analysis upon delivery. Licensing options are available as well.